At our session at MedTech Summit 2021, we were joined by Sara Garbin, Senior Clinical Development Scientist at Philips and Alison Ramsey, Director/Head, Clinical Evaluations at Alcon for an insightful discussion about how leveraging automation can improve manual...
The introduction of new guidelines for the diagnostics industry, outlined by the In-Vitro Diagnostics Regulation (EU) 2017/746 (known as IVDR), imposes significant changes for many manufacturers, who need a robust strategy to adequately support diagnostic products and...
A presentation at the Medical Librarian Association’s 2021 virtual conference brought together Jimmy McColery, Digital Education Specialist at Clarivate, and Jennifer Tetzlaff, DistillerSR’s Epidemiologist-in-Residence, to discuss how their respective solutions help...
Introduction On May 26, 2021, the European Union Medical Device Regulation (EU) 2017/745 (otherwise known as EU-MDR) went into effect for all member states, following a one-year extension due to the COVID-19 pandemic. The implementation of this regulation puts into...
One key component of realizing Evidence-informed decision making (EIDM) is ensuring decision makers have easy access to the best available evidence as quickly as possible. NCCMT does this through several initiatives including offering high-quality resources,...
Our clients screen over 50,000 references every day – over 4 million in total to date – and have completed thousands of reviews using our software. We’re often asked about citing the use of DistillerSR in publications and presentations, so we put together the...
We are currently living through an unprecedented global pandemic. All of our lives are impacted by COVID-19, whether we know someone personally affected by the virus or not. “Physical distancing” is quickly becoming the new normal in many communities. The critical...
This article originally appeared in The Ottawa Citizen by James Bagnall. When Ontario declared a COVID-19 health emergency last spring, the first instinct of Ottawa entrepreneur Peter O’Blenis was to preserve cash. “We basically stopped our discretionary spending,”...
Systematic reviews are a time-consuming and resource-intensive process. Even when the review is “small,” it’s common to see these projects take several months to complete. However, today there has been a shift in the needs of the systematic review community. More...
Although artificial intelligence technology is advancing at an incredible pace, it’s still common for researchers to hesitate when it comes to implementing it into their systematic review processes. Why? For many researchers, it comes down to uncertainty about the...